Connect Sign In
ARUP’s central pathology review service has provided key support for the Cogent SUMMIT trial through robust laboratory testing, mastocytosis pathology expertise, and rigorous quality standards.
ARUP has launched a highly sensitive and fully automated molecular assay to detect hepatitis delta virus (HDV) that will facilitate better detection of the virus.
At upcoming conferences, ARUP experts will highlight a new blood-based biomarker assay for Alzheimer’s disease and share a presentation on building a successful laboratory outreach program.
ARUP experts have received recognition from ADLM and the ADLM Academy for their remarkable achievements this year, winning Young Investigator Merit and Distinguished Abstracts awards.
A patient’s insistence on DPYD genotyping before chemotherapy highlights growing support for broader testing to prevent severe or fatal drug toxicity in patients.
The latest edition offers a look at ARUP’s advancements in the use of artificial intelligence for ova and parasite testing, highlights the importance of genetic testing, and features lifesaving tests.
ARUP experts will present on a variety of emerging topics at the American Society for Microbiology (ASM) conference, ASM Microbe 2025, which will be held June 19–23, 2025, in Los Angeles.
The ARUP Consult Viral Hepatitis topic was recently updated to reflect new recommendations and guidelines for testing, including ARUP’s new triple panel test.
ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing.
Join ARUP this Lab Week in investigating the latest advancements in lab science that empower medical laboratory science (MLS) detectives to solve cases more efficiently and effectively.
